Accessibility: Skip TopNav
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
The First and Only Anti-Amyloid Treatment in Japan that Enables At-Home Administration
Format
PNG
Quelle:
Biogen Inc.
Downloads
Originalgröße
Groß
Mittel
Klein